| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 645R07LF0D |
Structure
| InChI Key | KSGCNXAZROJSNW-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C19H15NO3S |
| Molecular Weight | 337.4 |
| AlogP | 4.44 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 60.17 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 24.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1A
Cytochrome P450 1A2
|
- | 5400 | - | - | - | |
|
Unclassified protein
|
110-1280 | - | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Muscular Dystrophy, Duchenne | 2 | D020388 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 945531-77-1 |
| ChEMBL | CHEMBL1773683 |
| DrugBank | DB12888 |
| EPA CompTox | DTXSID30241525 |
| FDA SRS | 645R07LF0D |
| Guide to Pharmacology | 11110 |
| PubChem | 25109292 |
| SureChEMBL | SCHEMBL732212 |
| ZINC | ZINC000071297091 |
CONTENTS